AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Pay a Past-Due Balance Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

The Authors’ Own Words: Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence

Mar 17, 2016 by AMERSA

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence
Heide Jackson , Kara Mandell , Kimberly Johnson , Debanjana Chatterjee , David J. Vanness
Substance Abuse
Vol. 36, Iss. 2, 2015

This study assesses the cost-effectiveness of XR-NTX for the treatment of opioid dependence. We find that public payors may be interested in adopting XR-NTX if they are willing to pay an additional $72 dollars per patient per day beyond treating patients with methadone maintenance treatment. The cost-effectiveness analysis is one component that may guide policy decisions; other factors like patient preferences and the effectiveness of treatment for other comorbid conditions may help determine the best course of treatment for particular subgroups.

Filed Under: SAj Blog, The Authors' Own Words

The Authors’ Own Words: Harm Reduction Agencies as a Potential Site for Buprenorphine Treatment

Mar 16, 2016 by AMERSA

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Harm Reduction Agencies as a Potential Site for Buprenorphine Treatment
Aaron D. Fox , Adam Chamberlain , Taeko Frost , Chinazo O. Cunningham
Substance Abuse
Vol. 36, Iss. 2, 2015

Our study demonstrates high levels of interest among harm reduction agency clients in initiating buprenorphine maintenance treatment onsite at harm reduction agencies. In the United States, harm reduction agencies already provide diverse services, including sterile syringe exchange, to people who use drugs, and they reach a unique population who may not use traditional medical or drug treatment services. Providing buprenorphine treatment onsite could better reach those in need of opioid addiction treatment than traditional approaches.

Filed Under: SAj Blog, The Authors' Own Words

The Authors’ Own Words: The Impact of Social Support and Attachment Style on Quality of Life and Readiness to Change in a Sample of Individuals Receiving Medication-Assisted Treatment for Opioid Dependence

Mar 15, 2016 by AMERSA

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

The Impact of Social Support and Attachment Style on Quality of Life and Readiness to Change in a Sample of Individuals Receiving Medication-Assisted Treatment for Opioid Dependence
Alan A. Cavaiola , Barbara A. Fulmer , David Stout
Substance Abuse
Vol. 36, Iss. 2, 2015

Social support is considered a vital factor in substance use disorder recovery. This research examines the types of social support behaviors that the opioid dependent individuals consider helpful and explores whether attachment style was a determining factor in whether social support was perceived as helpful. While social support predicted perceived improvement in overall quality of life and abstinence, secure attachment style did not predict improvement or with readiness to change as predicted (most participants fell within the Precontemplation category. Since social support was found to be important in one’s decision to initiate treatment and to maintain abstinence (with counselors and first-degree family members being identified as main supports. This suggests that counselors may increase positive treatment outcomes by developing positive, supportive therapeutic relationship with clients and by involving first-degree family members as soon as possible in the treatment process.

Filed Under: SAj Blog, The Authors' Own Words

The Authors’ Own Words: Developing a Research Career Focusing on a Stigmatized and Marginalized Population: Sexual Minority Women’s Drinking

Mar 14, 2016 by AMERSA

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Developing a Research Career Focusing on a Stigmatized and Marginalized Population: Sexual Minority Women’s Drinking
Tonda L. Hughes
Substance Abuse
Vol. 36, Iss. 2, 2015

Sexual minority women are a population group considered by the Institute of Medicines to be greatly understudied. Findings from Dr. Hughes’ studies have global implications for understanding sexual minority women’s high-risk health profiles, for improving the health and quality of life of both sexual minority and heterosexual populations, and for progress toward eliminating health disparities based on sexual orientation.

Filed Under: SAj Blog, The Authors' Own Words

The Authors’ Own Words: Psychiatric Morbidity in Ketamine Users Attending Counselling and Youth Outreach Services

Mar 10, 2016 by AMERSA

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Psychiatric Morbidity in Ketamine Users Attending Counselling and Youth Outreach Services
Wai Kwong Tang , Celia J. A. Morgan , Grace C. Lau , Hua Jun Liang , Alan Tang , Gabor S. Ungvari
Substance Abuse
Vol. 36, Iss. 1, 2015

The current findings suggest an enhancement of systematic screening on depression in ketamine users in Counseling Centres for Psychotropic Substance Abusers and other youth outreach services. Referral mechanism is available in those centres, however, without systematic screening, ketamine users with depressive symptoms may not receive the treatment which is deemed necessary and in turn affects the prognosis of their conditions.

Filed Under: SAj Blog, The Authors' Own Words

  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 38
  • Next Page »

Copyright © 2025
Site by: web360